Neogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Debt to equity
Neogen Corporation's debt to equity at the end of the quarter to 31 August 2026 was 0.4×, down 0.0× from fiscal 2026 (0.4×). Over the past ten years it has ranged from 0.0× (fiscal 2019) to 0.4× (fiscal 2025); the current reading is higher than 92% of that period. That is above the Medical Devices industry median of 0.0× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2026 | 0.4× | (12.16%) |
| FY2025 | 0.4× | 52.38% |
| FY2024 | 0.3× | (0.07%) |
| FY2023 | 0.3× | 25,672.73% |
| FY2022 | 0.0× | (8.33%) |
| FY2021 | 0.0× | (14.29%) |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Aug 2026 | 0.4× | (2.14%) |
| May 2026 | 0.4× | 0.50% |
| Feb 2026 | 0.4× | 0.13% |
| Nov 2025 | 0.4× | 0.72% |
| 43 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| BFLY Butterfly Network, Inc. compare | 0.0× |
| INSP Inspire Medical Systems, Inc. compare | 0.0× |
| ALMR Alamar Biosciences, Inc. compare | 0.0× |
| AXGN AxoGen, Inc. compare | 0.0× |
| TMDX TransMedics Group, Inc. compare | 0.1× |
| UFPT UFP Technologies, Inc. compare | 0.2× |
| NEOG Neogen Corporation | 0.4× |
| ITGR Integer Holdings Corporation compare | 0.7× |
| ESTA Establishment Labs Holdings Inc. compare | 12.1× |
| Medical Devices industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement